4th Annual MSK Symposium on Lymphoma

This symposium will feature updated information on lymphoma biology, diagnosis, immunology, and genetics, and ongoing efforts to translate the scientific discoveries into novel treatment strategies for a variety of lymphomas. Faculty will review the current standard of care and present their own perspectives on how they treat various types of lymphomas. Participants will have the opportunity to discuss diagnostic and management cases, and how to incorporate biologic and genetic biomarkers into clinical practice and clinical trials.

This symposium is designed for medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in diagnosis, treatment, and biomedical research of lymphoma.

Program Highlights

Networking Cocktail Reception (Friday, May 11, 5:20-6:30 pm) - Participants are invited to join course director, Dr. Anas Younes, and the entire course faculty for a cocktail reception on Friday evening in the lobby of Zuckerman Research Center. 

Special Luncheon Events - Participants are invited to attend two special luncheon events, one hosted by the Adult BMT Service and the other hosted by the Myeloma Service. RSVP for the luncheons is required and can be selected during course registration. Please note that space is limited and we do encourage early registration. 

• Adult BMT Luncheon Panel (Friday, May 10, 12:00-1:00 pm)
  Is there a Compelling Role for Hematopoietic Cell Transplantation in Early Relapsed or Refractory Follicular Lymphoma?
  This luncheon will feature updated information on treatment of hematological malignancies during the dawn of the era of immunotherapies in the form of checkpoint inhibitors and chimeric antigen receptor (CAR) T cells. Faculty will review the current standard curative therapy (hematopoietic cell transplantation) and how it has evolved. Participants will have the opportunity to ask questions regarding diagnosis and management, and how to determine treatment standards for the best chance of cure.
• Myeloma Luncheon Panel (Saturday, May 11, 12:30-1:30 pm)
  Advances in the Treatment and Monitoring of Multiple Myeloma
  This luncheon will provide information on use of CAR-T therapy in myeloma and methods to detect low levels of disease by mass spectrometry. Faculty will provide their perspective on the future of these techniques in multiple myeloma. Participants will have the opportunity to discuss how to incorporate these new approaches into clinical practice and clinical trials. 

New Live Simulcast Available

We are pleased to offer a live simulcast for the 4th Annual MSK Symposium on Lymphoma, available to attendees unable to attend this course in person. CME credit will still be offered for the live simulcast and active participation is required throughout the symposium. We do hope you will attend in person but understand that can sometimes be a challenge so we are happy to offer the live simulcast as an option. Register for the live simulcast here

1. provide up-to-date information on recent molecular diagnostic methods
2. provide up-to-date information on recent updates to lymphoma pathology classification
3. provide up-to-date information on recent treatment options for patients with Hodgkin and non-Hodgkin lymphoma

Course registration includes continental breakfast, lunch, and refreshment breaks. Please contact [email protected] at least one week prior to the course if you have any special dietary requests or require any specific accommodations.

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities.

Registration Discounts/Promotions

• MSK CME offers a 30% discounted rate for MSK Alumni, MSK Cancer Alliance and Cancer Care Partners. If you are a member of one of these groups, please contact [email protected] for more information.
• MSK employee registration is complimentary. However, you must complete course registration in order to attend this course.

Please note: after your payment has been processed, no further promotional discount adjustments will be made to your registration.

Cancellation Policy

If you cancel your participation in this course, your registration fee, less a $75 administrative fee, will be refunded when email notification is received by the MSK Office of Continuing Medical Education (MSK CME) at least 7 days prior to the first day of the course ([email protected]).

Cancellations or no-shows after this date are not eligible for a refund. MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, we will refund the registration fee in full, but are not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies. At any time, you may substitute another registrant in your place after contacting MSK CME with the relevant information.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 17.50 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity. 

MSK Course Director

Anas Younes, MD
Chief, Lymphoma Service

MSK Organizing Committee

Ahmet Dogan, MD, PhD
Hans Guido Wendel, MD
Joachim Yahalom, MD, FACR
Andrew Zelenetz, MD, PhD

MSK Course Faculty

Maria E. Arcila, MD
Connie Lee Batlevi, MD, PhD
Steven M. Horwitz, MD
Erel Joffe, MD
Anita Kumar, MD
Ross L. Levine, MD
Sham Mailankody, MBBS
Alison J. Moskowitz, MD
Ariela Noy, MD
M. Lia Palomba, MD
Gunjan L. Shah, MD
David J. Straus, MD 
Katie Thoren, MD

Invited Course Faculty

Philippe Armand, MD, PhD
Dana-Farber Cancer Institute 
Boston, MA

Elías Campo, MD
University of Barcelona
Spain

Riccardo Dalla-Favera, MD
Columbia University
New York, NY

Andrew M. Evens, DO, MSc, FACP
Rutgers Cancer Institute of New Jersey
New Brunswick, NJ

Massimo Federico, MD
University of Modena and Reggio Emilia
Italy
 
Jude Fitzgibbon, PhD
Barts Cancer Institute
England

Michele Ghielmini, MD
Oncology Institute of Southern Switzerland
Switzerland

Steven Le Gouill, MD
University of Nantes
France

Michael R. Green
The University of Texas MD Anderson Cancer Center
Houston, TX

Helen E Heslop, MD, DSc (Hon)
Baylor College of Medicine
Houston, TX

Peter Johnson MA, MD, FRCP
University of Southampton
United Kingdom

Ralf Küppers, PhD
Institute of Cell Biology (Cancer Research)
University of Duisburg-Essen
Germany

Tak W. Mak, PhD
University Health Network
Canada

Jürgen Ruland, MD
TUM School of Medicine
Germany 

Reiner Siebert, MD
University Hospital Ulm
Germany

Louis M. Staudt, MD, PhD
National Cancer Institute
Bethesda, MD

Laurie Sehn, MD, MPH
BC Cancer Agency
Canada

David M. Weinstock, MD
Dana-Farber Cancer Institute
Boston, MA

Pier-Luigi Zinzani, PhD
University of Bologna, 
Italy

Faculty Disclosures (All Faculty)

Memorial Sloan Kettering gratefully acknowledges the following organizations for providing independent medical educational grants and financial support for this live activity:

• AbbVie
  Celgene Corporation 
  Gilead Sciences 
  Janssen Research & Development, LLC 
  Novartis
  Seattle Genetics, Inc.